Document Detail

Modification of bone graft by blending with lecithin to improve hydrophilicity and biocompatibility.
MedLine Citation:
PMID:  18458499     Owner:  NLM     Status:  MEDLINE    
Lecithin was blended to improve the hydrophilicity and biocompatibility of bone graft containing poly(l-lactic acid) (PLLA). Solution blending and freeze drying were used to fabricate symmetrical scaffolds containing different percentages of lecithin (lecithin: PLLA = 0, 5, 10 wt%). Scanning electron microscopy showed that the scaffolds maintained the three-dimensional porous structure. A water uptake experiment proved the significant improvement of hydrophilicity of the blend scaffold. With the addition of lecithin, the compressive strength and compressive modulus decreased. When the weight ratio of lecithin to PLLA was up to 10%, the compressive strength was still more than the lower limit of natural cancellous bone. To test the biocompatibility of the scaffolds, cell culture in vitro and subcutaneous implantation in vivo were performed. MC3T3-E1 preosteoblastic cells were cultured on the scaffolds for 7 days. Methylthiazol tetrazolium assay and laser scanning confocal microscopy were used to exhibit proliferation and morphology of the cells. The subcutaneous implantation in rats tested inflammatory response to the scaffolds. The results proved the better biocompatibility and milder inflammatory reactions of the blend scaffold (lecithin: PLLA = 5%) compared with the scaffold without lecithin. The modified scaffold containing lecithin is promising for bone tissue engineering.
Y Wang; F Z Cui; Y P Jiao; K Hu; D D Fan
Related Documents :
19674779 - Finite element study of scaffold architecture design and culture conditions for tissue ...
17904679 - In vitro and in vivo test of peg/pcl-based hydrogel scaffold for cell delivery applicat...
16052509 - Performance of polyoxymethylene plastic (pom) as a component of a tissue engineering bi...
19496679 - Tranexamic acid--an alternative to aprotinin in fibrin-based cardiovascular tissue engi...
17518609 - Cyclic straining of cell-seeded synthetic ligament scaffolds: development of apparatus ...
16256789 - In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extr...
11721449 - Spontaneous activation of hamster oocytes in vitro.
9228789 - Localization of cellobiose dehydrogenase in cellulose-grown cultures of phanerochaete c...
7823769 - Glomerular endothelial cells promote mesangial cell growth via a pdgf-like substance.
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-03-03
Journal Detail:
Title:  Biomedical materials (Bristol, England)     Volume:  3     ISSN:  1748-605X     ISO Abbreviation:  Biomed Mater     Publication Date:  2008 Mar 
Date Detail:
Created Date:  2008-05-06     Completed Date:  2008-06-04     Revised Date:  2010-03-11    
Medline Journal Info:
Nlm Unique ID:  101285195     Medline TA:  Biomed Mater     Country:  England    
Other Details:
Languages:  eng     Pagination:  015012     Citation Subset:  IM    
Biomaterials Laboratory, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
3T3 Cells
Bone Substitutes / administration & dosage*,  chemistry*
Bone Transplantation / methods*
Cell Proliferation / drug effects*
Lactic Acid / administration & dosage*,  chemistry*
Lecithins / administration & dosage*,  chemistry*
Materials Testing
Polymers / administration & dosage*,  chemistry*
Reg. No./Substance:
0/Bone Substitutes; 0/Lecithins; 0/Polymers; 26100-51-6/poly(lactic acid); 50-21-5/Lactic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Image-based characterization of foamed polymeric tissue scaffolds.
Next Document:  Controlled release of 9-nitro-20(S)-camptothecin from methoxy poly(ethylene glycol)-poly(D,L-lactide...